Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Herceptin and Vinorelbine for HER2-Positive Metastatic Breast Cancer: A Phase II Study

Herceptin and Vinorelbine for HER2-Positive Metastatic Breast Cancer: A Phase II Study. Proc Am Soc Clin Oncol. 2000; 19(abstr 392).


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.